Zhengtao Chu

1.9k total citations
38 papers, 1.1k citations indexed

About

Zhengtao Chu is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Zhengtao Chu has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Immunology and 10 papers in Physiology. Recurrent topics in Zhengtao Chu's work include Phagocytosis and Immune Regulation (12 papers), Lipid Membrane Structure and Behavior (10 papers) and Erythrocyte Function and Pathophysiology (7 papers). Zhengtao Chu is often cited by papers focused on Phagocytosis and Immune Regulation (12 papers), Lipid Membrane Structure and Behavior (10 papers) and Erythrocyte Function and Pathophysiology (7 papers). Zhengtao Chu collaborates with scholars based in United States, China and Netherlands. Zhengtao Chu's co-authors include Xiaoyang Qi, Robert S. Franco, Victor Blanco, Jiayou Chu, Jin Li, Subrahmanya Vallabhapurapu, David P. Witte, Jun Xu, Min Wu and Wei Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Zhengtao Chu

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengtao Chu United States 19 542 294 237 210 121 38 1.1k
Marina Cardó‐Vila United States 25 1.0k 1.9× 345 1.2× 76 0.3× 118 0.6× 100 0.8× 31 1.7k
Daniel Rajotte United States 16 996 1.8× 307 1.0× 52 0.2× 131 0.6× 50 0.4× 19 1.5k
Karin Gaensler United States 20 1.0k 1.9× 131 0.4× 76 0.3× 468 2.2× 44 0.4× 42 1.4k
Paola Corti Italy 21 512 0.9× 168 0.6× 238 1.0× 149 0.7× 156 1.3× 65 1.4k
Hao‐Ping Liu Taiwan 19 661 1.2× 157 0.5× 135 0.6× 67 0.3× 90 0.7× 52 1.2k
Chad May United States 22 1.4k 2.5× 420 1.4× 213 0.9× 791 3.8× 68 0.6× 35 2.7k
Anna Coenen-Stass United Kingdom 17 741 1.4× 238 0.8× 55 0.2× 67 0.3× 65 0.5× 28 1.1k
Aron M. Levin United States 10 1.1k 2.0× 862 2.9× 91 0.4× 198 0.9× 42 0.3× 10 2.0k
Helen Priddle United Kingdom 16 1.2k 2.2× 461 1.6× 83 0.4× 185 0.9× 25 0.2× 22 1.9k
Russell Bainer United States 13 988 1.8× 250 0.9× 98 0.4× 91 0.4× 57 0.5× 20 1.7k

Countries citing papers authored by Zhengtao Chu

Since Specialization
Citations

This map shows the geographic impact of Zhengtao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengtao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengtao Chu more than expected).

Fields of papers citing papers by Zhengtao Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengtao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengtao Chu. The network helps show where Zhengtao Chu may publish in the future.

Co-authorship network of co-authors of Zhengtao Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengtao Chu. A scholar is included among the top collaborators of Zhengtao Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengtao Chu. Zhengtao Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsen, Sarah Naomi, Charlie Hatton, Zhengtao Chu, et al.. (2025). Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer. Cell Reports Medicine. 6(7). 102192–102192. 1 indexed citations
2.
Chu, Zhengtao, et al.. (2025). MFAP2 promotes the progress of esophageal squamous cell carcinoma by enhancing PTGS2 signaling. Journal of Cancer. 16(9). 2846–2856. 1 indexed citations
3.
Vaklavas, Christos, Cindy Matsen, Zhengtao Chu, et al.. (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precision Oncology. 8(8). e2300724–e2300724. 3 indexed citations
4.
Hou, Niuniu, Guangdong Hou, Bo Zhang, et al.. (2024). Radiotherapy and increased risk of second primary cancers in breast cancer survivors: An epidemiological and large cohort study. The Breast. 78. 103824–103824. 2 indexed citations
5.
Sun, Ying, Benjamin Liou, Zhengtao Chu, et al.. (2020). Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease. EBioMedicine. 55. 102735–102735. 26 indexed citations
6.
Davis, Harold W., Zhengtao Chu, Subrahmanya Vallabhapurapu, et al.. (2020). Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. Molecular Therapy. 28(8). 1876–1886. 16 indexed citations
7.
Chu, Zhengtao, Min Jiang, Sheryl E. Koch, et al.. (2017). mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment. Molecular Cancer Therapeutics. 16(11). 2432–2441. 13 indexed citations
8.
Blanco, Victor, Zhengtao Chu, Brian D. Gray, et al.. (2016). Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles. Oncotarget. 7(22). 32866–32875. 15 indexed citations
9.
Sulaiman, Mahaboob Khan, Zhengtao Chu, Victor Blanco, et al.. (2015). SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Molecular Cancer. 14(1). 78–78. 13 indexed citations
10.
Vallabhapurapu, Subrahmanya, Victor Blanco, Mahaboob Khan Sulaiman, et al.. (2015). Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium. Oncotarget. 6(33). 34375–34388. 100 indexed citations
11.
Blanco, Victor, Tahir Latif, Zhengtao Chu, & Xiaoyang Qi. (2015). Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Translational Oncology. 8(3). 196–203. 19 indexed citations
12.
Wojton, Jeffrey, Zhengtao Chu, Haritha Mathsyaraja, et al.. (2013). Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma. Molecular Therapy. 21(8). 1517–1525. 46 indexed citations
13.
Chu, Zhengtao, Shadi Abu‐Baker, Mary B. Palascak, et al.. (2013). Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer. PLoS ONE. 8(10). e75507–e75507. 37 indexed citations
14.
Qi, Xiaoyang, et al.. (2012). Saposin C Coupled Lipid Nanovesicles Specifically Target Arthritic Mouse Joints for Optical Imaging of Disease Severity. PLoS ONE. 7(3). e33966–e33966. 13 indexed citations
15.
Abu‐Baker, Shadi, et al.. (2012). Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles. Journal of Cancer Therapy. 3(4). 321–326. 23 indexed citations
16.
Qi, Xiaoyang, Zhengtao Chu, Yonatan Y. Mahller, et al.. (2009). Cancer-Selective Targeting and Cytotoxicity by Liposomal-Coupled Lysosomal Saposin C Protein. Clinical Cancer Research. 15(18). 5840–5851. 52 indexed citations
17.
Qi, Xiaoyang & Zhengtao Chu. (2004). Fusogenic domain and lysines in saposin C. Archives of Biochemistry and Biophysics. 424(2). 210–218. 37 indexed citations
18.
Tao, Yufen, Xiaoqin Huang, Zhengtao Chu, et al.. (2004). [Polymorphism of HLA-DRB1 in Han population in Yunnan and comparison with 9 Han populations].. PubMed. 26(6). 787–92. 4 indexed citations
19.
Chu, Zhengtao, David P. Witte, & Xiaoyang Qi. (2004). Saposin C–LBPA interaction in late-endosomes/lysosomes. Experimental Cell Research. 303(2). 300–307. 49 indexed citations
20.
Qian, Yaping, Bin‐Zhi Qian, Bing Su, et al.. (2000). Multiple origins of Tibetan Y chromosomes. Human Genetics. 106(4). 453–454. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Cardó‐Vila Breakdown of academic impact, for papers by Daniel Rajotte Breakdown of academic impact, for papers by Karin Gaensler Breakdown of academic impact, for papers by Paola Corti Breakdown of academic impact, for papers by Hao‐Ping Liu Breakdown of academic impact, for papers by Chad May Breakdown of academic impact, for papers by Anna Coenen-Stass Breakdown of academic impact, for papers by Aron M. Levin Breakdown of academic impact, for papers by Helen Priddle Breakdown of academic impact, for papers by Russell Bainer
Rankless by CCL
2026